Feature

Research Reports

The Role and Scope of Practice of Advanced Practice Providers in United States Community Oncology

04/21/2020

Ajeet Gajra , MD, FACP;

Ting-Chun Yeh , PhD;

Chadi Nabhan , MD, MBA, FACP;

Yolaine J. Jeune-Smith , PhD;

Bruce A. Feinberg , DO;

Andrew J. Klink , PhD, MPH;

Bela Bapat , MS;

Abstract: In the era of value-based care and constrained resources, oncology practices are increasingly employing advanced practice providers (APPs) to improve practice workflow, increase efficiency, and enable...

...

04/21/2020

Journal of Clinical Pathways

From the Field

Design and Integration of Predictive Modeling in the Oncology Clinical Setting to Reduce Readmissions

04/21/2020

Tammy Brown , MSN, RN, NEA-BC, OCN;

Vernon Alders , MHCDS, MBA, MSW1;

Kelsey Jarrold , MSISE;

Raghad Alkhawaldeh , PhD-c2;

Karen Sites , MSN, RN, OCN, CCM;

Courtney Crannell , DNP, MSN, RN-BC, OCN;

Abstract: A multidisciplinary team at ChristianaCare, headquartered in Wilmington, DE, designed a comprehensive pathway utilizing an internally developed predictive model to proactively reduce oncology...

...

04/21/2020

Journal of Clinical Pathways

Research Reports

Real-World Analysis of Outpatient Rasburicase to Prevent and Manage Tumor Lysis Syndrome in Newly Diagnosed Adults With Leukemia or Lymphoma

03/16/2020

Alex R. Cockerham , PharmD, RPh, MSc;

William Irish , PhD;

Edward Drea , PharmD;

Michael P. Ryan , MS;

Lucio Gordan , MD;

Yvonne Barnes , DNP, RN;

Scott C. Howard , MD, MSc;

Abstract: Rasburicase, a recombinant urate oxidase used to manage hyperuricemia in patients at risk of tumor lysis syndrome, is increasingly being used in outpatient settings, but outcomes with this approach have not...

...

03/16/2020

Journal of Clinical Pathways

Perspectives

The Challenge of Developing Pathways in a Rapidly Evolving Clinical Space: Chronic Lymphocytic Leukemia as a Case Study

03/16/2020

Ray Page , DO, PhD, FACOI, FASCO;

Andrew Hertler , MD, FACP;

Steve L. D'Amato , BSPharm, BCOP;

Michael Kolodziej , MD;

Barry Brooks , MD;

William A. Flood , MD, MS;

Abstract: Clinical pathways represent an effort to optimize value-based clinical decision making by standardizing (when appropriate) evidence-based care to offer patients the best outcome while remaining mindful of...

...

03/16/2020

Journal of Clinical Pathways

$Real-World Management and Outcomes of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated in the United States$

Research Reports

Real-World Management and Outcomes of Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated in the United States

02/18/2020

Andrew J. Klink , PhD, MPH;

Anna G. Purdum , PharmD, MS;

Chadi Nabhan , MD, MBA, FACP;

Bruce A. Feinberg , DO;

Choo Hyung Lee , MS;

Yin Yang , MS;

JaLyna Laney , RN, OCN;

Abstract: Given new therapeutic advances that are potentially curative in diffuse large B-cell lymphoma (DLBCL), it is important to understand what has been observed to date in this population to assess improvement...

...

02/18/2020

Journal of Clinical Pathways

Research Reports

Use of Clinical Decision Support and Peer Review to Increase NCCN Guideline Adherence

02/18/2020

Margaret Rausa , PharmD;

Stephen Hamilton , MD;

David Spangler ;

Eric Gratias , MD, FAAP;

Abstract: eviCore healthcare uses the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines®) to support its proprietary program for medical oncology drug management. The...

...

02/18/2020

Journal of Clinical Pathways

Perspectives

The Oncology Care Model: Performance Period 4 Results and the Next Phase With Two-Sided Risk

12/17/2019

Charles Saunders , MD;

Abstract: The Oncology Care Model has reached yet another major milestone, releasing its year-three results in August 2019. Though participants have shared concerns over potential weaknesses in the program, like...

...

12/17/2019

Journal of Clinical Pathways

Research Reports

Quality Improvement Pilot Project to Standardize a Prehabilitation Program for Patients With Esophageal Cancer Receiving Neoadjuvant Chemoradiation

12/17/2019

Karyn Goodman , MD, MS;

Megan D. Marsh , PA;

S. Lindsey Davis , MD;

Lisa J. Wingrove , RD;

Ashley E. Glode , PharmD, BCOP;

Supriya K. Jain , MD;

Lindel C.K. Dewberry , MD;

Martin D. McCarter , MD;

Michelle Bunch , CSW;

Tracey E. Schefter , MD;

Laura Melton , PhD;

Abstract: A standard treatment recommendation for esophageal cancer patients with stage IB-IIIB disease is for neoadjuvant chemoradiation followed by surgery. This trimodality therapy can be difficult for patients to...

...

12/17/2019

Journal of Clinical Pathways

Perspectives

Integrating Palliative Care Into the Oncology Care Model via Clinical Pathways

11/18/2019

Joshua M. Liao , MD, MSc, FACP;

Nikita V. Baclig , MD, MPH;

Abstract: Participants in the Oncology Care Model (OCM) have both the opportunity and need to drive performance by building upon strong historical foundations in oncology clinical pathways and by promoting outcomes...

...

11/18/2019

Journal of Clinical Pathways

From the Field

A Community Practice Perspective on Implementation of Nursing Triage Pathways

11/18/2019

Anne Marie Fraley Rainey , MSN, RN, CHC;

Abstract: Clearview Cancer Institute is a private, community practice participating in the Oncology Care Model, an innovative pilot project sponsored by the Center for Medicare and Medicaid Innovation. Over the...

...

11/18/2019

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Feature

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products